⌘K

Login Start Free

Home/Filings/4/0001127602-25-001201

4//SEC Filing

Nicholson Nur 4

Accession 0001127602-25-001201

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:22 PM ET

Size

4.7 KB

Accession

0001127602-25-001201

Insider Transaction Report

Form 4

Period: 2025-01-13

Apellis Pharmaceuticals, Inc.APLS

Chief Technical Officer

Transactions

Sale
Common Stock
2025-01-13$28.70/sh−2,632$75,544→ 54,156 total

Footnotes (2)

[F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 10, 2025.
[F2]This includes 501 shares from April 30, 2024 ESPP purchase.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1

filerCIK 0001827317

Filing Metadata

Form type: 4
Filed: Jan 13, 7:00 PM ET
Accepted: Jan 14, 4:22 PM ET
Size: 4.7 KB

View on SEC.gov